SPEVOLZA Trademark

Trademark Overview


On Friday, September 4, 2020, a trademark application was filed for SPEVOLZA with the United States Patent and Trademark Office. The USPTO has given the SPEVOLZA trademark a serial number of 79295628. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, July 19, 2023. This trademark is owned by NOVARTIS AG. The SPEVOLZA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
spevolza

General Information


Serial Number79295628
Word MarkSPEVOLZA
Filing DateFriday, September 4, 2020
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, July 19, 2023
Registration Number6274825
Registration DateTuesday, February 23, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 8, 2020

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateWednesday, July 19, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Friday, December 29, 2023INTERNATIONAL REGISTRATION RENEWED
Monday, August 7, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, August 7, 2023DEATH OF INTERNATIONAL REGISTRATION
Sunday, April 18, 2021NOTIFICATION PROCESSED BY IB
Friday, March 26, 2021FINAL DISPOSITION NOTICE SENT TO IB
Friday, March 26, 2021FINAL DISPOSITION PROCESSED
Thursday, March 25, 2021GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, February 23, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, December 8, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 8, 2020PUBLISHED FOR OPPOSITION
Wednesday, November 18, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 2, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, November 2, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 2, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, November 2, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 2, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 2, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, November 2, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 27, 2020APPLICATION FILING RECEIPT MAILED
Friday, October 23, 2020ASSIGNED TO EXAMINER
Wednesday, October 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 20, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, October 8, 2020SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB